https://www.selleckchem.com/pr....oducts/canagliflozin
Patients with prior coronary artery bypass graft surgery (CABG) are at increased risk for recurrent cardiovascular ischaemic events. Advances in management have improved prognosis of patients with acute coronary syndrome (ACS), yet it is not known whether similar trends exist in patients with prior CABG. Examine temporal trends in the prevalence, treatment and clinical outcomes of patients with prior CABG admitted with ACS. Time-dependent analysis of patients with or without prior CABG admitted with an ACS who enrolled in the ACS